Xilio Therapeutics, Inc. Intellectual Property Contracts & Agreements

5 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration, License and Option Agreement between Xilio Development, Inc. and AbbVie Group Holdings Limited (February 10, 2025)
License Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2025
License Agreement between Xilio Development, Inc. and Gilead Sciences, Inc. (March 27, 2024)
License Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2024
CTLA-4 Monoclonal Antibody License Agreement between WuXi Biologics (Hong Kong) Limited and Akriveia Therapeutics Inc.
License Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2021
Amended and Restated Exclusive License Agreement between Akriveia Therapeutics Inc. and City of Hope
License Agreements
Xilio Therapeutics, Inc.
Biotechnology
CA
2021
Cross-License Agreement between Xilio Development, Inc. and AskGene Pharma, Inc. (Effective December 16, 2020)
License Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2021